Health is critical to our wellbeing as individuals, plays a key role in societal and economic advances, and presents many opportunities for environmental impact. Innovations in health & care allow us to alleviate suffering, increase quality of life and life expectancy, and manage the needs of a changing and ageing population.
Our current focus in this area
The digital health and care sub-sector is characterised by a large number of small companies developing technology across the health spectrum.
The medicines sector is characterised by a few large pharmaceutical companies and a large number of SME biotech companies.
Medical technologies touch all of our lives – from pregnancy testing and ultrasound scans before birth; through wound care products for childhood injuries; to diagnostic imaging systems and therapeutic implants for disease in adults.
From bioelectronic medicine that treat chronic diseases, to brain-computer interfaces that help stroke rehabilitation, neurotechnology will play an increasingly important role in meeting some of the challenges of an ageing society.
Precision Medicine aims to target the right drug, to the right patient, at the right dose and the right time. Precision Medicine is a cutting-edge field of innovation that improves disease outcome by tailoring treatments to characteristics of patients.
The Microbiome Innovation Network (formerly SIG) aims to accelerate the commercialisation of microbiome-based products and services in the UK and create a vibrant community by connecting industry and academia.
The application of Artificial Intelligence and machine learning to the field of health represents a major opportunity for the UK. AI is a powerful tool that can be applied across industry sectors to solve specific challenges. The application of these tools in Health requires a mutual understanding between the AI and Health communities.
Canada-UK: Biomanufacturing of Biologics and Advanced Therapies
Opens: 26/06/2023 Closes: 17/10/2023
UK registered organisations can apply for a share of up to £3.5m to collaborate with Canadian SMEs on joint R&D to innovate in biomanufacturing biologics and advanced therapies.
Flexible, agile, scalable and sustainable medicines manufacturing
Opens: 26/09/2023 Closes: 22/11/2023
UK registered organisations can apply for a share of up to £5m for development and implementation of technologies for medicines development and manufacture.
Biomedical Catalyst 2023 Round 2: Industry-led R&D
Opens: 20/09/2023 Closes: 08/11/2023
UK registered SMEs can apply for a share of up to £20 million to develop innovative solutions to health and healthcare challenges.
Related Events and Recordings
Horizon Europe Health (Cluster 1) Consortia Building Event
09.30 - 12.30 | Online
UK Phage Innovation Showcase
09.30 - 16.30 | Leicester/online
Medicines Made Smarter: Data, AI, Robotics and the future of medicines manufacturing
12.00 - 13.00 | Online
Gabriela Juarez Martinez
Knowledge Transfer Manager - Pharma & MedTech
Contact Gabriela Juarez Martinez
Help us shape the future of innovation!
Innovate UK is looking to expand their assessor pool to review applications in the Health and Life Sciences area. Join us and be part of a vibrant community of experts dedicated to driving innovation forward.
Pilot accelerators launched to support the development of early-stage health and life science innovation in the UK
We are pleased to announce our pilot accelerators, in collaboration with the Medical Research Council (MRC), which will allow spinouts, start-ups, and entrepreneurial minded academics to test their ideas and develop concepts with support from key stakeholders from the innovation ecosystem.
Exploring Microbiome Innovation: Insights from the Microbiome One Health Conference
Over 100 microbiome researchers and innovators gathered in Glasgow in March 2023 for the sold-out Microbiome One Health Conference, organised by members of the Innovate UK KTN Microbiome Innovation Advisory Board and the Health and AgriFood teams.
Programmes related to Health
Helps transform innovative ideas into commercially viable businesses.
Health Funding Map
The map was developed by Innovate UK KTN and the BioIndustry Association (BIA) with the help of a wide range of funders. It helps in the navigation of the complicated world of health innovation funding.
Medimap: End-to-end medicines supply chain map
Medimap is a new interactive reference tool for the UK medicines sector, mapping and categorising over 3,000 sites of organisations engaged in or supporting the end-to-end supply chain for medicines.